| MAR |
Report |
System-wide RevPAR Growth (Q2 2026) |
BEAT |
pred ~+2.4% vs. cons +2.0% |
MEDIUM |
| MAR |
Report |
Gross Fees (Q2 2026) |
IN-LINE |
pred ~$1,565M vs. cons $1,554.6M |
MEDIUM |
| MAR |
Report |
Adj. EPS Diluted Operating (Q2 2026) |
BEAT |
pred ~$3.12 vs. cons $3.085 |
MEDIUM |
| MAR |
Guide |
FY 2026 Global RevPAR Growth (FY 2026) |
BETTER |
guide ~+3.0% mid vs. cons +2.52% |
MEDIUM |
| MAR |
Guide |
FY 2026 Gross Fees (FY 2026) |
UNCHANGED |
guide ~$6,005M mid vs. cons $5,999.8M |
MEDIUM |
| MAR |
Guide |
FY 2026 Adj. EPS (FY 2026) |
UNCHANGED |
guide ~$11.675 mid vs. cons $11.663 |
MEDIUM |
| MAR |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.5% |
— |
MEDIUM |
| MAR |
Return |
5-day cumulative residual |
+2.5% (STABILIZE) |
STABILIZE — FY guide midpoint lands at consensus; limited sell-side revision catalyst; credit card renewal optionality and World Cup narrative provide a floor |
MEDIUM |